Background: To identify characteristic morphological changes of the retina, their change over time and the association with visual function after combined photodynamic therapy (PDT) and intravitreal triamcinolone (IVTA). Methods: In this retrospective study, 40 patients (40 eyes) were treated with PDT and same day IVTA. Optical coherence tomography (OCT), fluorescein angiography (FA) and...
Date First Received: May 23, 2008
Last Updated: May 27, 2008
Verified by: Medical University of Vienna, May 2008
Clinical Trial Phase: Phase 3 | Start Date: January 2004
Overall Status: Completed
Estimated Enrollment: 40
Brief Summary
Condition Keyword(s):
Intervention(s):
Background: To identify characteristic morphological changes of the retina, their change over time and the association with visual function after combined photodynamic therapy (PDT) and intravitreal triamcinolone (IVTA).
Methods: In this retrospective study, 40 patients (40 eyes) were treated with PDT and same day IVTA. Optical coherence tomography (OCT), fluorescein angiography (FA) and evaluation of distance visual acuity (VA) were performed. Main outcome measures were the anatomical changes within intra- and subretinal compartments and their detailed analysis and grading.
Study Type: Interventional
Study Design: Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment
Study Primary Completion Date: January 2006
Intervention(s) in this Clinical Trial
- Other: PDT plus intravitreal triamcinolone
- PDT plus intravitreal triamcinolone
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- cnv secondary to age related macular degeneration
Exclusion Criteria:
- glaucoma, diabetic retinopathy
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 50 Years
Maximum Age for this Clinical Trial: 85 Years
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Sponsor Information
Lead Sponsor: Medical University of Vienna
Additional Information
Information obtained from ClinicalTrials.gov on August 28, 2008
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00685100
Study ID Number: 002
ClinicalTrials.gov Identifier: NCT00685100
Health Authority: United States: Institutional Review Board
Clinical Trials Authorship and Review
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
